SCHEMBL25305701

SCHEMBL25305701

CC(C)(C)CC(NC(=O)C(=O)Nc1ccccc1F)C(=O)NC(C[C@@H]1CCNC1=O)C(=O)COC(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25305703 1.00 — —
SCHEMBL24939332 1.00 — —
SCHEMBL30276942 0.94 CTSL (0.43) —
SCHEMBL25855481 0.94 CTSL (0.43) —
SCHEMBL24939091 0.92 — —
SCHEMBL30276962 0.92 — —
SCHEMBL24939394 0.92 — —
SCHEMBL30276973 0.91 CTSL (0.48) —
SCHEMBL24710026 0.91 CTSL (0.48) —
SCHEMBL30277048 0.88 CASP3 (0.54) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11708348-B2 Protease inhibitors for treatment of coronavirus infections THE SCRIPPS RESEARCH INSTITUTE (US) 2023-07-25 — — US disclosed
Send feedback